Dr. Claude Piché is a co-founder and the President and CEO of Locemia Solutions, a privately-held specialty pharma company. At Locemia, Claude led the creation and development of Baqsimi, a needle-free rescue treatment for severe hypoglycemia for people who take insulin; the product was acquired and has since been launched world-wide by Eli Lilly. Prior to forming Locemia, Claude worked at private, public, and start-up biopharmaceutical companies with hands-on experience in research, regulatory affairs, marketing, operations and business development.
Claude is an active investor and advisor in numerous private biopharma and medical device companies. He serves on the board of four privately held companies.
He holds degrees from the University of Saskatchewan (DVM) and the University of Calgary (MSc). He is an author of over 30 peer-reviewed scientific publications and over 40 scientific abstracts and presentations.